Silchester International Investors LLP Sells 2,786,538 Shares of Nutrien Ltd. $NTR

Silchester International Investors LLP lessened its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 35.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,981,447 shares of the company’s stock after selling 2,786,538 shares during the period. Nutrien accounts for approximately 95.7% of Silchester International Investors LLP’s investment portfolio, making the stock its biggest position. Silchester International Investors LLP owned about 1.03% of Nutrien worth $292,461,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Norges Bank acquired a new stake in shares of Nutrien in the second quarter valued at approximately $395,842,000. Arrowstreet Capital Limited Partnership increased its stake in shares of Nutrien by 48.5% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,944,730 shares of the company’s stock worth $696,058,000 after acquiring an additional 3,900,755 shares during the last quarter. Boston Partners purchased a new position in shares of Nutrien during the 2nd quarter worth $150,416,000. First Eagle Investment Management LLC raised its holdings in shares of Nutrien by 14.0% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,268,229 shares of the company’s stock worth $772,742,000 after acquiring an additional 1,627,328 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of Nutrien by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 21,903,308 shares of the company’s stock valued at $1,276,328,000 after acquiring an additional 712,305 shares during the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Trading Down 2.3%

Shares of NYSE NTR opened at $60.69 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 0.89 and a debt-to-equity ratio of 0.39. The stock has a market capitalization of $29.29 billion, a PE ratio of 16.36 and a beta of 0.72. Nutrien Ltd. has a twelve month low of $45.78 and a twelve month high of $65.08. The stock has a fifty day simple moving average of $59.33 and a 200-day simple moving average of $58.71.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, November 5th. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.06. The company had revenue of $5.82 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Nutrien had a return on equity of 7.54% and a net margin of 6.79%.Nutrien’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same period last year, the business posted $0.39 EPS. On average, equities analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Wednesday, December 31st will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a yield of 3.6%. The ex-dividend date of this dividend is Wednesday, December 31st. Nutrien’s dividend payout ratio is presently 58.76%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on NTR. UBS Group cut their price objective on shares of Nutrien from $63.00 to $58.00 and set a “neutral” rating for the company in a research report on Thursday, November 6th. Wells Fargo & Company started coverage on shares of Nutrien in a report on Tuesday, November 11th. They set an “equal weight” rating and a $64.00 price target for the company. Scotiabank decreased their price objective on Nutrien from $65.00 to $63.00 and set a “sector perform” rating on the stock in a report on Monday, November 10th. Zacks Research cut Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 16th. Finally, Bank of America restated a “neutral” rating and issued a $67.00 target price on shares of Nutrien in a research report on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, fourteen have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Nutrien has a consensus rating of “Hold” and an average target price of $63.17.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.